• リン酸化 • response to testosterone • positive regulation of fibroblast proliferation • response to hyperoxia • positive regulation of translation • regulation of cell cycle • 細胞分裂 • タンパク質リン酸化 • lens development in camera-type eye • regulation of cell population proliferation • response to lead ion • 概日リズム • animal organ regeneration • positive regulation of cell population proliferation • positive regulation of cell size • positive regulation of apoptotic process • 遺伝子発現調節 • 細胞周期 • positive regulation of G2/M transition of mitotic cell cycle • 毒性物質への反応 • positive regulation of cell cycle • シグナル伝達 • 多細胞個体の発生 • 有機物への反応 • cellular response to insulin stimulus • regulation of multicellular organism growth • regulation of insulin receptor signaling pathway • regulation of lipid biosynthetic process • regulation of lipid catabolic process • 脂肪組織発生 • cellular response to lipopolysaccharide • cellular response to interleukin-4 • cellular response to phorbol 13-acetate 12-myristate • cellular response to ionomycin • transcription initiation from RNA polymerase II promoter • G1/S transition of mitotic cell cycle • regulation of cyclin-dependent protein serine/threonine kinase activity • negative regulation of G1/S transition of mitotic cell cycle
^Sheppard, K. E.; McArthur, G. A. (2013-10-01). “The Cell-Cycle Regulator CDK4: An Emerging Therapeutic Target in Melanoma” (英語). Clinical Cancer Research19 (19): 5320–5328. doi:10.1158/1078-0432.CCR-13-0259. ISSN 1078-0432. PMID (24089445).
^Sobhani; D’Angelo; Pittacolo; Roviello; Miccoli; Corona; Bernocchi; Generali et al. (2019-04-06). “Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer” (英語). Cells8 (4): 321. doi:10.3390/cells8040321. ISSN 2073-4409.
^“Physical interaction of mammalian CDC37 with CDK4”. J. Biol. Chem.271 (36): 22030–4. (1996). doi:10.1074/jbc.271.36.22030. PMID (8703009).
^“Interaction between Cdc37 and Cdk4 in human cells”. Oncogene14 (16): 1999–2004. (1997). doi:10.1038/sj.onc.1201036. PMID (9150368).
^“Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4”. Genes Dev.10 (12): 1491–502. (1996). doi:10.1101/gad.10.12.1491. PMID (8666233).
^ ab“Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells”. Proc. Natl. Acad. Sci. U.S.A.97 (16): 9042–6. (2000). doi:10.1073/pnas.160016897. PMC 16818. PMID (10908655). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC16818/.
^ ab“Towards a proteome-scale map of the human protein-protein interaction network”. Nature437 (7062): 1173–8. (2005). Bibcode: 2005Natur.437.1173R. doi:10.1038/nature04209. PMID (16189514).
^“A skeleton of the human protein interactome”. Cell122 (6): 830–2. (2005). doi:10.1016/j.cell.2005.09.006. PMID (16179252).
^“Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function”. Genes Dev.8 (24): 2939–52. (1994). doi:10.1101/gad.8.24.2939. PMID (8001816).
^“C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4”. Mol. Cell8 (4): 817–28. (2001). doi:10.1016/S1097-2765(01)00366-5. PMID (11684017).
^“Calmodulin is essential for cyclin-dependent kinase 4 (Cdk4) activity and nuclear accumulation of cyclin D1-Cdk4 during G1”. J. Biol. Chem.273 (50): 33279–86. (1998). doi:10.1074/jbc.273.50.33279. PMID (9837900).
^ ab“Identification of CDK4 sequences involved in cyclin D1 and p16 binding”. J. Biol. Chem.272 (30): 18869–74. (1997). doi:10.1074/jbc.272.30.18869. PMID (9228064).
^“Developmentally regulated expression of cyclin D3 and its potential in vivo interacting proteins during murine gametogenesis”. Endocrinology140 (6): 2790–800. (1999). doi:10.1210/endo.140.6.6756. PMID (10342870).
^“Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation”. EMBO J.18 (24): 6983–93. (1999). doi:10.1093/emboj/18.24.6983. PMC 1171761. PMID (10601020). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1171761/.
^“Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A”. Curr. Biol.6 (1): 84–91. (1996). doi:10.1016/S0960-9822(02)00425-6. PMID (8805225).
^ ab“The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner”. Biochemistry43 (14): 4394–9. (2004). doi:10.1021/bi035601s. PMID (15065884).
^“Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation”. Genes Dev.7 (8): 1572–83. (1993). doi:10.1101/gad.7.8.1572. PMID (8101826).
関連文献
Hanks SK (1987). “Homology probing: identification of cDNA clones encoding members of the protein-serine kinase family”. Proc. Natl. Acad. Sci. U.S.A.84 (2): 388–92. Bibcode: 1987PNAS...84..388H. doi:10.1073/pnas.84.2.388. PMC 304212. PMID (2948189). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC304212/.
Hall M; Bates S; Peters G (1995). “Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins”. Oncogene11 (8): 1581–8. PMID (7478582).
Tassan JP; Jaquenoud M; Léopold P et al. (1995). “Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C”. Proc. Natl. Acad. Sci. U.S.A.92 (19): 8871–5. Bibcode: 1995PNAS...92.8871T. doi:10.1073/pnas.92.19.8871. PMC 41069. PMID (7568034). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC41069/.
Mitchell EL; White GR; Santibanez-Koref MF et al. (1995). “Mapping of gene loci in the Q13-Q15 region of chromosome 12”. Chromosome Res.3 (4): 261–2. doi:10.1007/BF00713052. PMID (7606365).
Wölfel T; Hauer M; Schneider J et al. (1995). “A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma”. Science269 (5228): 1281–4. doi:10.1126/science.7652577. PMID (7652577).
Hirai H; Roussel MF; Kato JY et al. (1995). “Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6”. Mol. Cell. Biol.15 (5): 2672–81. doi:10.1128/MCB.15.5.2672. PMC 230497. PMID (7739547). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC230497/.
Chan FK; Zhang J; Cheng L et al. (1995). “Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4”. Mol. Cell. Biol.15 (5): 2682–8. doi:10.1128/MCB.15.5.2682. PMC 230498. PMID (7739548). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC230498/.
Guan KL; Jenkins CW; Li Y et al. (1995). “Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function”. Genes Dev.8 (24): 2939–52. doi:10.1101/gad.8.24.2939. PMID (8001816).
Kato JY; Matsuoka M; Strom DK; Sherr CJ (1994). “Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase”. Mol. Cell. Biol.14 (4): 2713–21. doi:10.1128/MCB.14.4.2713. PMC 358637. PMID (8139570). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC358637/.
Khatib ZA; Matsushime H; Valentine M et al. (1993). “Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas”. Cancer Res.53 (22): 5535–41. PMID (8221695).
Serrano M; Hannon GJ; Beach D (1994). “A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4”. Nature366 (6456): 704–7. doi:10.1038/366704a0. PMID (8259215).
Demetrick DJ; Zhang H; Beach DH (1994). “Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes”. Cytogenet. Cell Genet.66 (1): 72–4. doi:10.1159/000133669. PMID (8275715).
Kato J; Matsushime H; Hiebert SW et al. (1993). “Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4”. Genes Dev.7 (3): 331–42. doi:10.1101/gad.7.3.331. PMID (8449399).
Zuo L; Weger J; Yang Q et al. (1996). “Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma”. Nat. Genet.12 (1): 97–9. doi:10.1038/ng0196-97. PMID (8528263).
Knudsen ES; Wang JY (1996). “Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites”. J. Biol. Chem.271 (14): 8313–20. doi:10.1074/jbc.271.14.8313. PMID (8626527).
Poon RY; Jiang W; Toyoshima H; Hunter T (1996). “Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage”. J. Biol. Chem.271 (22): 13283–91. doi:10.1074/jbc.271.22.13283. PMID (8662825).
Stepanova L; Leng X; Parker SB; Harper JW (1996). “Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4”. Genes Dev.10 (12): 1491–502. doi:10.1101/gad.10.12.1491. PMID (8666233).
Dai K; Kobayashi R; Beach D (1996). “Physical interaction of mammalian CDC37 with CDK4”. J. Biol. Chem.271 (36): 22030–4. doi:10.1074/jbc.271.36.22030. PMID (8703009).
Fåhraeus R; Paramio JM; Ball KL et al. (1996). “Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A”. Curr. Biol.6 (1): 84–91. doi:10.1016/S0960-9822(02)00425-6. PMID (8805225).